Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies
Clinical trial NCT01061749 · COMPLETED
Trial details
- NCT number
- NCT01061749
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2013-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.